BI
NVAX icon

Binnacle Investments’s Novavax NVAX Stock Holding History

Binnacle Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$451 Buy
+52
New +$405 ﹤0.01% 866
2025
Q2 		– Sell
-52
Closed -$333 – 832
2025
Q1 		$333 Buy
+52
New +$430 ﹤0.01% 742

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Binnacle Investments's NVAX Position: Q3 2025 in Review

Binnacle Investments opened a new position in Novavax (NVAX) in Q3 2025: 52 shares worth $451. The stake represents ﹤0.01% of the portfolio and ranks #866 among its holdings. This is a return to the name: Binnacle Investments previously reported a position in NVAX as recently as Q1 2025.

Binnacle Investments first reported a position in NVAX in Q1 2025 and has held it in 2 quarters since. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Binnacle Investments held 52 shares of Novavax worth $451 as of Q3 2025.
  • Novavax was a new Binnacle Investments position in Q3 2025.
  • Novavax made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #866 holding.
  • Binnacle Investments first reported a position in Novavax in Q1 2025 and has held it in 2 quarters since.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.